itraconazole has been researched along with Cytomegalovirus Infections in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleibtreu, A; Diamantis, S; Grégoire, V; Lehur, AC; Picard, A; Pluvy, J; Rioux, C; Vallois, D; Zielinski, M | 1 |
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
Bando, T; Chen, F; Date, H; Hotta, G; Ichiyama, S; Ito, Y; Kato, K; Matsubara, K; Matsuda, Y; Matsumura, Y; Nagao, M; Nakano, S; Takakura, S; Yamamoto, M; Yunoki, T | 1 |
Ando, K; Fukushima, T; Hata, T; Honda, S; Imaizumi, Y; Imanishi, D; Itonaga, H; Matsuo, E; Miyazaki, Y; Moriuchi, Y; Onimaru, Y; Sato, S; Sawayama, Y; Taguchi, J; Tsushima, H; Yamasaki, R; Yoshida, S | 1 |
Bouza, E; Desco, M; Domínguez, MJ; Muñoz, P; Palomo, J; Rodríguez, C; Yañez, JF | 1 |
Cheng, B | 1 |
7 other study(ies) available for itraconazole and Cytomegalovirus Infections
Article | Year |
---|---|
Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Diagnosis, Differential; Female; Haiti; Histoplasmosis; HIV Infections; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Maxillary Diseases; Middle Aged; Osteolysis | 2017 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
Itraconazole prophylaxis for invasive Aspergillus infection in lung transplantation.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Case-Control Studies; Cytomegalovirus Infections; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Renal Replacement Therapy; Retrospective Studies; Risk Factors; Tracheotomy | 2014 |
Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bacterial Infections; Cytomegalovirus Infections; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Japan; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Analysis; Transplantation, Homologous | 2013 |
Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Cytomegalovirus; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Regression Analysis; Risk; Risk Factors; Time Factors; Treatment Outcome | 2004 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |